Connect to other sites within the UBM Medica Network
New CML Risk Score Incorporates Modern Survival Probability
A new risk assessment score more accurately reflects the probability of dying from chronic myeloid leukemia than do existing scoring systems.
Five New Risk Loci Identified for Gliomas
A new genetic analysis found five new genetic variants that raise the risk for gliomas. One of the five was associated with a sharply increased risk for glioblastoma.
Chemo During Pregnancy Did Not Affect Early Child Development
Children exposed to their mother’s cancer and cancer treatment did not appear to have cardiac, cognitive, or general developmental issues up to 36 months of age.
Intermittent Imatinib Feasible in Elderly CML Patients
Treatment with intermittent imatinib is feasible among elderly CML patients who are stable responders to the drug, according to a new study.
Scrotum Swelling in 57-Year-Old Patient
A 57-year-old man presents with swelling of the scrotum. What is your diagnosis?
Some Breast Cancer Patients Can Forgo Chemotherapy
Some patients with early-stage HR-positive breast cancer can be treated with hormone therapy alone, avoiding chemo without increasing their recurrence risk.
Public Awareness of Surgical Options for Breast Cancer Improves
Significantly more women are now aware of reconstructive surgery options after mastectomies for breast cancer, following coverage of Angelina Jolie’s mastectomies in 2013.
Nab-Paclitaxel Shows Benefit in Advanced Melanoma
Treatment with nab-paclitaxel resulted in significantly improved progression-free survival and a greater disease control rate in chemotherapy-naive patients with metastatic melanoma compared with dacarbazine.
Obesity Associated With Increased Thyroid Cancer Risk
Overweight and obesity are associated with the risk for thyroid cancer. Relations between BMI and cancer risk showed some variation based on tumor histologic type.
Colorectal Tumors Differ By Age
A study showed that tumors of younger patients with early-onset colorectal cancer differ from the tumors of those diagnosed later in life, both genetically and epigenetically.
By clicking Accept, you agree to become a member of the UBM Medica Community.